[Rapid and secure exclusion of myocardial infarctionwithout ST-segment elevation]

Autor: Abdullahi Ahmed, Mohamed, Tayfun, Basaran, Gro, Egholm, Jens Flensted, Lassen, Jesper, Revsholm, Jonas Angel, Sjøland

Publikováno v: Ugeskrift for laeger. 183(49)

Rapid identification of acute myocardial infarction (MI) is important for the early initiation of evidence-based therapy. In the European Society of Cardiology (ESC) 0/1h-algorithm (also called early-rule-out algorithm) high-sentivity cardiac troponi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::a635a4190754112213f8349d04c33761
https://pubmed.ncbi.nlm.nih.gov/34895440

Lupus anticoagulant is significantly associated with inflammatory reactions in patients with suspected deep vein thrombosis

Autor: Johannes Jakobsen Sidelmann, Jonas Angel Sjøland, Jørgen Gram, H Münster, T Mourits-Andersen, Jørgen Jespersen, Anna-Marie Bloch Münster, V Bertelsen

Publikováno v: Sidelmann, J J, Sjøland, J A, Gram, J, Bertelsen, V, Mourits-Andersen, T, Münster, H, Münster, A-M B & Jespersen, J 2007, ' Lupus anticoagulant is significantly associated with inflammatory reactions in patients with suspected deep vein thrombosis ', Scandinavian Journal of Clinical & Laboratory Investigation, vol. 67, no. 3, pp. 270-279 . https://doi.org/10.1080/00365510601038992

OBJECTIVE: Lupus anticoagulant (LA) and antiphospholipid antibodies (aPL) are suggested as risk factors for development of deep vein thrombosis (DVT) among patients without systemic lupus erythematosus (SLE). Other conditions, e.g. inflammation, are

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::60453106657e8f8533d49a066a411520
https://pubmed.ncbi.nlm.nih.gov/17454841

Intraperitoneal heparin reduces peritoneal permeability and increases ultrafiltration in peritoneal dialysis patients.

Autor: Jonas Angel Sjøland, Robert Smith Pedersen, Jørgen Jespersen, Jørgen Gram

Publikováno v: Nephrology Dialysis Transplantation; May2004, Vol. 19 Issue 5, p1264-1268, 5p

Fibrin clot structure in patients with end-stage renal disease

Autor: Johannes Jakobsen Sidelmann, Jørgen Gram, Kristina F. Standeven, Jørgen Houe Pedersen, Robert A. S. Ariëns, Mikkel Brabrand, Jonas Angel Sjøland, Kim H. Esbensen, R.S. Pedersen

Publikováno v: University of Southern Denmark
Sjøland, J, Sidelmann, J, Brabran, M, Pedersen, R, Pedersen, J H, Esbensen, K, Standeven, K, Ariëns, R & Gram, J 2007, ' Fibrin clot structure in patients with end-stage renal disease ', Thrombosis and Haemostasis, vol. 98, no. 2, pp. 339-345 .
Sjøland, J A, Sidelmann, J J, Brabrand, M, Pedersen, R S, Pedersen, J H, Esbensen, K, Standeven, K F, Ariëns, R A S & Gram, J B 2007, ' Fibrin clot structure in patients with end-stage renal disease ', Thrombosis and Haemostasis, vol. 98, pp. 339-345 .

SummaryFibrin clots with reduced permeability, increased clot stiffness and reduced fibrinolysis susceptibility may predispose to cardiovascular disease (CVD). Little is known, however, about the structure of fibrin clots in patients with end-stage r

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dbf9e60b7e55672466e8379e655e91fe
https://portal.findresearcher.sdu.dk/en/publications/827dab50-dad7-11dc-860c-000ea68e967b